Overview

Study to Compare the Pharmacokinetics, Safety, and Tolerability Following Administration of Palovarotene in Healthy Japanese and Non-Asian Subjects

Status:
Completed
Trial end date:
2015-10-23
Target enrollment:
Participant gender:
Summary
this study purpose is to assess safety, tolerability and the pharmacokinetic (PK) profile of palovarotene in healthy Japanese and matched (with respect to sex, age, and weight) non-Asian subjects aged 18 to 55 years.
Phase:
Phase 1
Details
Lead Sponsor:
Clementia Pharmaceuticals Inc.